Clinical utility of comprehensive genomic profiling in 175 Japanese patients with advanced skin malignancies refractory to standard therapies
In this multicenter retrospective analysis, we evaluated the outcomes of CGP in 175 patients with melanoma, nonmelanoma skin cancers, and cutaneous sarcomas treated at 7 academic institutions in Japan.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- Correction: Primary cutaneous adenoid cystic carcinoma of the right forearm: a case report and dermoscopic features
- A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug
- Deciphering the potential pathogeny of rare tracheal adenoid cystic carcinoma by single‑cell RNA‑sequencing
- Adenoid cystic carcinoma (ACC)
- DAY301 | Day One Biopharmaceuticals